Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction
JAMA Cardiol 2021 Feb 17;[EPub Ahead of Print], DD Berg, PS Jhund, KF Docherty, SA Murphy, S Verma, SE Inzucchi, L Køber, MN Kosiborod, AM Langkilde, FA Martinez, O Bengtsson, P Ponikowski, M Sjöstrand, SD Solomon, JJV McMurray, MS SabatineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.